Rose Lai
Impact in
Papers in
- Genetics 16
- Glioma Diagnosis and Treatment 16
-
- Brain Metastases and Treatment 8
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Lisa M. DeAngelis (7 shared papers)Lauren E. Abrey (7 shared papers)Marc K. Rosenblum (2 shared papers)Joachim Yahalom (5 shared papers)Denise D. Correa (5 shared papers)Jeffrey J. Raizer (4 shared papers)David Schiff (3 shared papers)Barbara Grant (3 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Neuro-Oncology (4 papers)Neurology (3 papers)Cancer (2 papers)Annals of Oncology (2 papers)
- Partner nations
- United StatesCanadaChina
In The Last Decade
Rose Lai
45 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 117
- Genetics 908
- Neurology 793
- Pathology and Forensic Medicine 643
- Cancer Research 343
- Oncology 353
Countries citing papers authored by Rose Lai
This map shows the geographic impact of Rose Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rose Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rose Lai more than expected).
Fields of papers citing papers by Rose Lai
This network shows the impact of papers produced by Rose Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rose Lai. The network helps show where Rose Lai may publish in the future.
Co-authors
The 25 scholars most cited alongside Rose Lai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 316 | |
| 2 | 2007 | 281 | |
| 3 | 2016 | 261 | |
| 4 | 2004 | 123 | |
| 5 | 2002 | 122 | |
| 6 | 2004 | 121 | |
| 7 | 2011 | 117 | |
| 8 | 1996 | 98 | |
| 9 | 2006 | 86 | |
| 10 | 2005 | 68 | |
| 11 | 2008 | 57 | |
| 12 | 2009 | 50 | |
| 13 | 2014 | 44 | |
| 14 | 2012 | 41 | |
| 15 | 2022 | 28 | |
| 16 | 2012 | 23 | |
| 17 | 2022 | 23 | |
| 18 | 2019 | 23 | |
| 19 | 1982 | 22 | |
| 20 | 2021 | 22 |
About Rose Lai
Rose Lai is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Molecular Biology, Oncology and Cancer Research, having authored 45 papers that have together received 2.0k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (16 papers), Brain Metastases and Treatment (8 papers), CNS Lymphoma Diagnosis and Treatment (6 papers), Cancer-related molecular mechanisms research (5 papers), HER2/EGFR in Cancer Research (4 papers), Lung Cancer Treatments and Mutations (4 papers), RNA modifications and cancer (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Genetics (908 citations), Neurology (793 citations), Pathology and Forensic Medicine (643 citations), Cancer Research (343 citations) and Oncology (353 citations). Rose Lai has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Lisa M. DeAngelis, Lauren E. Abrey, Marc K. Rosenblum, Joachim Yahalom, Denise D. Correa, Jeffrey J. Raizer, David Schiff, Barbara Grant, Gaurav Shah and Lehana Thabane. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Neurology, Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.